News from pdl biopharma, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 29, 2015, 07:35 ET

PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals

 PDL BioPharma, Inc. (NASDAQ: PDLI) today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which...

Jul 28, 2015, 16:02 ET

PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015

 PDL BioPharma, Inc. (PDL, or the Company) (NASDAQ: PDLI) today announced that the Company will release its second quarter 2015 financial...

Jun 29, 2015, 17:09 ET

PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications

 PDL BioPharma, Inc. (NASDAQ: PDLI) today announced that it has entered into a credit agreement with CareView Communications, Inc. (OTCQB:...

Jun 25, 2015, 07:00 ET

PDL BioPharma to Present at the Nasdaq 32nd Investor Program

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will...

Jun 24, 2015, 07:00 ET

PDL BioPharma Appoints Steffen Pietzke as Controller and Chief Accounting Officer

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the company has appointed Steffen Pietzke, CPA, to the position of controller...

Jun 15, 2015, 07:00 ET

PDL BioPharma Completes Regular Quarterly Dividend Payment

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the June 12, 2015, regular quarterly dividend payment of $0.15 per...

May 27, 2015, 07:00 ET

PDL BioPharma to Present at Jefferies 2015 Global Healthcare Conference

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will...

May 06, 2015, 16:02 ET

PDL BioPharma Announces First Quarter 2015 Financial Results

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the first quarter ended March 31, 2015. Total revenues for the...

Apr 29, 2015, 07:00 ET

PDL BioPharma to Announce First Quarter 2015 Financial Results on May 6, 2015

PDL BioPharma, Inc. (PDL, or the Company) (NASDAQ: PDLI) today announced that the Company will release its first quarter 2015 financial results for...

Mar 12, 2015, 16:02 ET

PDL BioPharma Completes Regular Quarterly Dividend Payment

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the March 12, 2015, regular quarterly dividend payment of $0.15...

Mar 04, 2015, 16:02 ET

PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the: - 3.75% Convertible Senior Notes due May...

Mar 03, 2015, 07:00 ET

PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit

 PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that the third of three shareholder lawsuits filed in the fall of...

Feb 26, 2015, 07:00 ET

PDL BioPharma to Hold Annual Meeting of Stockholders on May 28, 2015

 PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that the Company will hold its annual meeting of stockholders on...

Feb 23, 2015, 16:07 ET

PDL BioPharma Announces Fourth Quarter and Full Year 2014 Financial Results

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the fourth quarter and year ended December 31, 2014. Total...

Feb 17, 2015, 07:00 ET

PDL BioPharma to Announce Fourth Quarter and Full Year 2014 Financial Results on February 23, 2015

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its fourth quarter and full year 2014 financial results...

Feb 04, 2015, 07:00 ET

PDL BioPharma to Present at Upcoming Investor Conferences

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will...

Jan 29, 2015, 07:00 ET

PDL BioPharma Announces 2015 Regular Quarterly Dividends

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that its board of directors has declared that the regular, quarterly dividends to be...

Dec 15, 2014, 16:02 ET

PDL BioPharma Completes Regular Quarterly Dividend Payment

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the December 12, 2014, regular quarterly dividend payment of $0.15...

Dec 10, 2014, 16:02 ET

PDL BioPharma Provides Fourth Quarter 2014 Revenue Guidance of $158 Million

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced revenue guidance for the fourth quarter ending December 31, 2014, of approximately...

Dec 04, 2014, 16:01 ET

PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the: - 3.75% Convertible Senior Notes...